These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22149143)

  • 21. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.
    Laeyendecker O; Brookmeyer R; Mullis CE; Donnell D; Lingappa J; Celum C; Baeten JM; Campbell MS; Essex M; de Bruyn G; Farquhar C; Quinn TC; Eshleman SH;
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1177-83. PubMed ID: 22283149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary subtype C HIV-1 infection in Harare, Zimbabwe.
    Tien PC; Chiu T; Latif A; Ray S; Batra M; Contag CH; Zejena L; Mbizvo M; Delwart EL; Mullins JI; Katzenstein DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):147-53. PubMed ID: 10048901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 subtypes among blood donors from Rio de Janeiro, Brazil.
    Tanuri A; Swanson P; Devare S; Berro OJ; Savedra A; Costa LJ; Telles JG; Brindeiro R; Schable C; Pieniazek D; Rayfield M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):60-6. PubMed ID: 9928731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of new CRF43_02G and CRF25_cpx in Saudi Arabia based on full genome sequence analysis of six HIV type 1 isolates.
    Yamaguchi J; Badreddine S; Swanson P; Bodelle P; Devare SG; Brennan CA
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1327-35. PubMed ID: 18844465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity considerations in HIV-1 vaccine selection.
    Gaschen B; Taylor J; Yusim K; Foley B; Gao F; Lang D; Novitsky V; Haynes B; Hahn BH; Bhattacharya T; Korber B
    Science; 2002 Jun; 296(5577):2354-60. PubMed ID: 12089434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of human immunodeficiency virus type-1 from HIV-1 seropositive cases with undetectable viremia.
    Yang C; Li M; Cowart F; Rudolph D; Parekh B; McDougal JS; Lal RB
    J Clin Virol; 2004 Jul; 30(3):224-8. PubMed ID: 15135739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV type 1 subtype surveillance in central Kenya.
    Kageha S; Lihana RW; Okoth V; Mwau M; Okoth FA; Songok EM; Ngaira JM; Khamadi SA
    AIDS Res Hum Retroviruses; 2012 Feb; 28(2):228-31. PubMed ID: 21740274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 pol sequences from India fit distinct subtype pattern.
    Soto-Ramirez LE; Tripathy S; Renjifo B; Essex M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(4):299-307. PubMed ID: 8948366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
    Shafer RW; Eisen JA; Merigan TC; Katzenstein DA
    J Virol; 1997 Jul; 71(7):5441-8. PubMed ID: 9188616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin.
    Gao F; Robertson DL; Morrison SG; Hui H; Craig S; Decker J; Fultz PN; Girard M; Shaw GM; Hahn BH; Sharp PM
    J Virol; 1996 Oct; 70(10):7013-29. PubMed ID: 8794346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.
    Binley JM; Klasse PJ; Cao Y; Jones I; Markowitz M; Ho DD; Moore JP
    J Virol; 1997 Apr; 71(4):2799-809. PubMed ID: 9060635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Near full-length genetic analysis of HIV sequences derived from Cyprus: evidence of a highly polyphyletic and evolving infection.
    Kousiappa I; Van De Vijver DA; Kostrikis LG
    AIDS Res Hum Retroviruses; 2009 Aug; 25(8):727-40. PubMed ID: 19619035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between susceptibility of primary HIV-1 isolates to autologous and heterologous neutralizing antibodies. Hospital Evandro Chagas AIDS Clinical Research Group.
    Bongertz V; Costa CI; Santos VG; João Filho EC; Galvão-Castro B; Morgado MG
    AIDS; 1997 Jul; 11(8):969-75. PubMed ID: 9223730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
    Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
    PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence in India of HIV type 1 similar to North American strains.
    Baskar PV; Ray SC; Rao R; Quinn TC; Hildreth JE; Bollinger RC
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):1039-41. PubMed ID: 7811535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine-induced HIV seropositivity: a problem on the rise.
    Van Braeckel E; Koutsoukos M; Bourguignon P; Clement F; McNally L; Leroux-Roels G
    J Clin Virol; 2011 Apr; 50(4):334-7. PubMed ID: 21300566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa.
    Imamichi H; Koita O; Dabitao D; Dao S; Ibrah M; Sogoba D; Dewar RL; Berg SC; Jiang MK; Parta M; Washington JA; Polis MA; Lane HC; Tounkara A
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):45-55. PubMed ID: 19182920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B' env molecular clones derived from infections in China.
    Xie H; Nie J; Chen Q; Huang W; Wang Y
    Emerg Microbes Infect; 2018 May; 7(1):90. PubMed ID: 29769530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope.
    Doria-Rose NA; Learn GH; Rodrigo AG; Nickle DC; Li F; Mahalanabis M; Hensel MT; McLaughlin S; Edmonson PF; Montefiori D; Barnett SW; Haigwood NL; Mullins JI
    J Virol; 2005 Sep; 79(17):11214-24. PubMed ID: 16103173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China.
    Wang S; Nie J; Wang Y
    Virus Res; 2011 Jan; 155(1):137-46. PubMed ID: 20875470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.